Primary Site >> Stomach Cancer

Gene >> CBR1

  • 1998
  • 2008
  • 2011
  • 2013
  • 2014
  • 2015
  • 2017
Ref: Evaluation of clinical benefit of chemotherapy in patients with upper gastrointestinal cancer.
PMID: 10050982
Ref: Phase II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer and/or adenocarcinoma of the gastroesophageal junction.
PMID: 17897959
Ref: Assessing clinical benefit response in the treatment of gastric malignant ascites with non-measurable lesions: a multicenter phase II trial of paclitaxel for malignant ascites secondary to advanced/recurrent gastric cancer.
PMID: 21327925
Ref: Clinical study of cisplatin hyperthermic intraperitoneal perfusion chemotherapy in combination with docetaxel, 5-flourouracil and leucovorin intravenous chemotherapy for the treatment of advanced-stage gastric carcinoma.
PMID: 23598741
Ref: Health economics evaluation of a gastric cancer early detection and treatment program in China.
PMID: 25040963
Ref: Evaluation and treatment of malignant ascites secondary to gastric cancer.
PMID: 26494952
Ref: Human carbonyl reductase 1 participating in intestinal first-pass drug metabolism is inhibited by fatty acids and acyl-CoAs.
PMID: 28450226